Skip to main content
LITTLE GREEN PHARMA LTD logo

LITTLE GREEN PHARMA LTD — Investor Relations & Filings

Ticker · LGP ISIN · AU0000074924 ASX Manufacturing
Open in API
Filings indexed 445 across all filing types
Latest filing 2026-03-22 Proxy Solicitation & In…
Country AU Australia
Listing ASX LGP

About LITTLE GREEN PHARMA LTD

https://www.littlegreenpharma.com/

Little Green Pharma Ltd is a vertically integrated medicinal cannabis company focused on the cultivation, production, and distribution of pharmaceutical-grade cannabis medicines. The company operates advanced cultivation and manufacturing facilities, producing a diverse range of products including oils and dried flower. Adhering to Good Manufacturing Practice (GMP) standards, it ensures product consistency and safety across its entire supply chain, from genetics and breeding to final delivery. Little Green Pharma serves both domestic and international markets, maintaining a significant presence in Europe, including Germany and the United Kingdom. The company is committed to advancing clinical research and development to support the therapeutic use of cannabis for various medical conditions, focusing on patient-centric care and high-quality delivery systems.

Recent filings

Filing Released Lang Actions
Notice of General Meeting 67 pages 1.0MB
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled 'Notice of General Meeting' and includes detailed information about the meeting date, time, location (virtual via Zoom), agenda items, resolutions to be voted on, voting exclusions, and proxy voting instructions. It also contains an Explanatory Memorandum that provides background on the proposed merger transaction and details about the resolutions. The content is typical of a notice sent to shareholders to inform them about an upcoming general meeting and to solicit their votes on specific resolutions. There is no financial data, earnings information, or audit content. The document is not a report itself but a notice and explanatory material for a shareholder meeting. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2026-03-22 English
Letter to Shareholders regarding General Meeting 2 pages 170.7KB
AGM Information Classification · 95% confidence The document is a notice to shareholders about an upcoming General Meeting, including details on virtual attendance, voting procedures, proxy submission, and where to find the Notice of Meeting and explanatory memorandum. It does not contain financial data, results, or detailed reports but serves as an invitation and instructions for participation in the meeting. The document length is under 5,000 characters and primarily functions as a meeting notice rather than the meeting materials themselves. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or notices related to it.
2026-03-22 English
Termination of proposed sale and leaseback transaction 2 pages 168.4KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 19 March 2026 regarding the termination of a proposed sale and leaseback transaction by Little Green Pharma Ltd. It references a prior announcement about the contract but primarily informs that the contract has terminated and the transaction will not proceed. The document is short (3573 characters) and serves as a formal announcement of a corporate event related to financing or capital structure (sale and leaseback). It does not contain financial statements, detailed financial data, or management discussion. It is not a report, earnings release, or regulatory filing of financial results. The content fits best under Capital/Financing Update (CAP) as it updates investors on a financing-related transaction status.
2026-03-18 English
Scheme Booklet Registered by ASIC 303 pages 4.7MB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 5 March 2026 from Little Green Pharma Ltd regarding the registration and dispatch of a Scheme Booklet related to the proposed acquisition of Cannatrek Ltd by way of a scheme of arrangement. It includes details about the Scheme Booklet, the Independent Expert's Report, board recommendations, voting intentions, and an indicative timetable for the scheme process. The document is primarily an announcement about the scheme process and the availability of the Scheme Booklet, rather than the Scheme Booklet itself or the full merger documentation. It also references the dispatch of notices of meeting and voting instructions. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement about the scheme and related shareholder meetings, not the full merger filing or proxy solicitation materials themselves. The document is lengthy (15,000 characters) but is an announcement rather than a full report or proxy statement. Therefore, the appropriate classification is Regulatory Filings (RNS).
2026-03-04 English
Dispatch of Scheme Booklet 3 pages 277.7KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 5 March 2026 from Little Green Pharma Ltd regarding the dispatch of a Scheme Booklet related to the proposed acquisition of Cannatrek Ltd by way of a scheme of arrangement. It describes the dispatch of the Scheme Booklet to shareholders, the inclusion of an Independent Expert's Report within the booklet, board recommendations, and voting intentions. The document does not contain the Scheme Booklet itself or detailed financial statements but announces the dispatch and availability of the Scheme Booklet. This fits the category of a Regulatory Filing (RNS) as it is an official announcement about a corporate action and the availability of related materials, not the materials themselves or a full merger filing form such as DEFM14A or SC TO-*.
2026-03-04 English
Results of First Court Hearing 4 pages 193.1KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 4 March 2026 from Little Green Pharma Ltd regarding the results of a first court hearing related to a proposed acquisition of Cannatrek Ltd by way of a scheme of arrangement. It details court orders, the convening of shareholder meetings, the dispatch of explanatory statements and notices, voting procedures, board recommendations, and an indicative timetable for the scheme process. The document does not contain financial statements or detailed financial analysis but rather provides procedural and meeting information related to the merger scheme. It is an announcement about the progress and procedural steps of a merger transaction, including shareholder meeting notices and court approvals, but does not itself constitute the merger filing or the scheme booklet. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement and does not fit other more specific categories such as M&A filings (which would include merger communications or proxy statements), nor is it a financial report or earnings release. The document length (9934 characters) and content confirm it is not a brief report publication announcement or a certification. Therefore, the appropriate classification is Regulatory Filings (RNS).
2026-03-03 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.